ArticleCancer chemotherapy and pharmacology2024

Predictive significance of inflammatory markers and mGPS in metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

Sabin Goktas Aydin et al.PubMed ↗Publisher ↗

No numbers read from the abstract.